Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06443320

Evaluation of the Videodrama Therapeutic Device for Children With Autism Spectrum Disorders

Autism spectrum disorder (ASD) is a neurodevelopmental disorder (Valerie, Sperenza, 2009) that begins early in development, characterized by persistent deficits in communication and social interactions across various contexts and restricted, repetitive patterns of behavior, interests, or activities. These symptoms significantly impact social, school/professional functioning, or other important areas and are not better explained by intellectual disability or global developmental delay (American Psychiatric Association, 2013).

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Autism Spectrum Disorder (ASD) Autism Spectrum Disorder Autistic Disorder Child Development Disorders, Pervasive Mental Disorders Neurodevelopmental Disorders

Age range

3 year–15 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

Currently, managing children with ASD emphasizes compensating for communication and social interaction disabilities. Communication tools like PECS or Makaton and social skills groups have shown effectiveness but have limitations, particularly not addressing sensory atypicalities seen in children with ASD. These sensory atypicalities are evident when children watch videos on screens. The idea is to use video to understand the sensory experiences of children with ASD and help them move away from an isolated relationship with screens. New technologies can further isolate children with ASD in their autistic sphere. The hypothesis is that observing these children with screens will provide better understanding of their sensory experiences and improve therapeutic support towards play and interaction with others

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children aged 3 to 15 years.
  • Clinically confirmed ASD by a psychiatrist.
  • Parental or legal guardian consent for participation.
  • Child showing a strong interest in screens and/or video content.
  • Ability to tolerate the presence of other children.
  • Minimum of 18 video drama sessions.
  • Not having benefited from disease care in the past.
  • Affiliation to a social security system

Exclusion criteria

  • No ASD diagnosis.
  • Younger than 3 or older than 15 at the study start.
  • No interest in screens or video content.
  • Parental or legal guardian refusal for participation.
  • Dropping out before completing 18 sessions.
  • Patient having benefited a disease care in the past

Treatment and study plan

patient included in experimental groupe will view the video excerpt, a playtime, a drawing activities

Other

Patients included in the videodrama arm will participate in a total of 18 videodrama sessions, with one session per week. Each session will include a patient welcome period, the viewing of a video excerpt (in slow motion or not), a playtime, a drawing period, and a group closing session. For the play and drawing activities, the same materials will be provided in each department and for each group, including small figurines, animals, shapes (such as cubes, triangles, circles), small plush toys, markers, colored pencils, and A4 white sheets of paper.

Primary outcomes

  1. Dunn Sensory Profile questionnaire

    Time frame: 9 months

    Sensory atypicality frequency will be assessed using the Dunn Sensory Profile questionnaire, describing child behavior in various sensory experiences

Secondary outcomes

  1. Cars-T questionnaire

    Time frame: 9 months

    Observe improvements in social skills (interaction and communication) in children with ASD, assessed by the Cars-T questionnaire,

  2. Sceno Test

    Time frame: 9 months

    Observation of the emergence of a symbolic game. This emergence will be evaluated by the passation of the scenotest, a test which reveals the different modalities of integration of the game.

Study contacts

Contact information is provided by the study sponsor or research team.

Constance LEMARCHAND

CONTACT

[email protected]

0182372332

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Intercommunal Robert Ballanger

Other

Registry information

Acronym: VIDEOTSA

Important dates

Study start
2023
Primary completion
2027
Study completion
2027
First posted
Jun 5, 2024
Registry last updated
Feb 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.